Cargando…

Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study

SIMPLE SUMMARY: Recurrence of cancer on the opposite side after the removal of primary upper tract urothelial carcinoma (UTUC) is uncommon, but the risk of subsequent deterioration of kidney function may be severe and result in the need for permanent dialysis. There is a clear correlation between in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chien, Tsu-Ming, Lee, Hsiang-Ying, Singla, Nirmish, Margulis, Vitaly, Lotan, Yair, Woldu, Solomon Lukasz, Huang, Chun-Nung, Li, Ching-Chia, Ke, Hung-Lung, Li, Wei-Ming, Li, Chia-Yang, Huang, A-Mei, Yang, Sheau-Fang, Tu, Hung-Pin, Wu, Wen-Jeng, Yeh, Hsin-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657377/ https://www.ncbi.nlm.nih.gov/pubmed/34885042 http://dx.doi.org/10.3390/cancers13235935

Ejemplares similares

Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2020)

Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation
por: Zhang, Lei, et al.
Publicado: (2015)

The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence
por: Lee, Hsiang-Ying, et al.
Publicado: (2018)

Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Ke, Hung-Lung, et al.
Publicado: (2022)

Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts
por: Tse, Jennifer, et al.
Publicado: (2019)

The Significance of Preoperative Serum Sodium and Hemoglobin in Outcomes of Upper Tract Urothelial Carcinoma: Multi-Center Analysis Between China and the United States
por: Fang, Dong, et al.
Publicado: (2020)

The Predictive Value of Systemic Immune-Inflammation Index on Bladder Recurrence on Upper Tract Urothelial Carcinoma Outcomes after Radical Nephroureterectomy
por: Chien, Tsu-Ming, et al.
Publicado: (2021)

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
por: Aydin, Ahmet Murat, et al.
Publicado: (2017)

Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
por: Pradere, Benjamin, et al.
Publicado: (2020)

Impact of cachexia on oncologic outcomes of sarcopenic patients with upper tract urothelial carcinoma after radical nephroureterectomy
por: Chen, Hao-Wei, et al.
Publicado: (2021)

Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma
por: von Deimling, Markus, et al.
Publicado: (2023)

Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2015)

AB90. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of methylation status
por: Zhang, Lei, et al.
Publicado: (2014)

Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
por: Chien, Tsu-Ming, et al.
Publicado: (2020)

Oncologic outcomes of radical nephroureterectomy (RNU)
por: Kenigsberg, Alexander P., et al.
Publicado: (2020)

Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan
por: Yu, Lian-Ching, et al.
Publicado: (2020)

Robot-Assisted Laparoscopic Nephroureterectomy versus Hand-Assisted Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: A Matched Comparison Study
por: Hu, Che-Yuan, et al.
Publicado: (2015)

Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan
por: Chen, I-Hsuan Alan, et al.
Publicado: (2022)

Evaluation of Hematuria in a Large Public Health Care System
por: Ghandour, Rashed, et al.
Publicado: (2019)

Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy
por: Chang, Li-Wen, et al.
Publicado: (2023)

Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma
por: Li, Yun-Ren, et al.
Publicado: (2020)

Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma
por: Li, Xiaoying, et al.
Publicado: (2020)

Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Disease Progression and Poor Prognosis in Upper Tract Urothelial Carcinoma
por: Su, Yung-Chun, et al.
Publicado: (2021)

Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma
por: Lin, Wei-Yu, et al.
Publicado: (2022)

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2016)

Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case report
por: Lu, Yen-Man, et al.
Publicado: (2016)

Endoscopic management versus radical nephroureterectomy for localized upper tract urothelial carcinoma in a high endemic region
por: Chen, Yung-Tai, et al.
Publicado: (2021)

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience
por: Yang, Chen-Kuang, et al.
Publicado: (2014)

AB91. Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center
por: Fang, Dong, et al.
Publicado: (2014)

Long-term oncologic outcomes of laparoscopic nephroureterectomy versus open nephroureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis
por: Zhang, Su, et al.
Publicado: (2016)

Biological and prognostic implications of biopsy upgrading for high‐grade upper tract urothelial carcinoma at nephroureterectomy
por: Katayama, Satoshi, et al.
Publicado: (2022)

Laparoscopic nephroureterectomy for upper tract urothelial carcinoma – Update
por: Lin, Victor C., et al.
Publicado: (2016)

Oncologic outcomes comparison of partial ureterectomy and radical nephroureterectomy for urothelial carcinoma
por: Li, Shengxian, et al.
Publicado: (2019)

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer
por: Yao, Lin, et al.
Publicado: (2016)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness
por: Liang, Peir-In, et al.
Publicado: (2016)

Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
por: Tsai, Meng-Chen, et al.
Publicado: (2016)

Nephroureterectomy increase 5 year survival in patients on dialysis with upper urinary tract urothelial carcinoma
por: Huang, Cih-En, et al.
Publicado: (2017)

Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_79c4or1ud69a7qep7eqeder8uk